A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program designed to facilitate the kind of precision genome editing involved in the development of cutting-edge therapeutics for genetic conditions such as certain metabolic or blood disorders, like sickle-cell anemia.